Compile Data Set for Download or QSAR
Report error Found 472 Enz. Inhib. hit(s) with all data for entry = 11219
TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM600924(US11634396, Compound 7 | 4-((S)-2-(dimethylamino)-...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM600945(US11634396, Compound 8 | 4-((S)-2-(dimethylamino)-...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM600961(US11634396, Compound 9 | 4-[(2S)-2-(dimethylamino)...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM600978(US11634396, Compound 10 | 4-((S)-2-(dimethylamino)...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601050(4-((S)-3-((R)-3-cyclopropyl-3-phenylpropanamido)-2...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601051(4-[(2S)-2-(dimethylamino)-3-[(3R)-5-methyl-3-pheny...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601052(4-[(2S)-3-[(3S)-4,4-dimethyl-3-phenylpentanamido]-...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601053(3-chloro-4-((S)-2-(dimethylamino)-3-((R)-3-phenylb...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601054(3-chloro-4-((S)-2-(dimethylamino)-3-((S)-3-phenylb...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601059(3-chloro-4-((S)-2-(dimethylamino)-3-((R)-3-(6-meth...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601060(3-chloro-4-[(2S)-2-(dimethylamino)-3-[(3R)-3-(2-me...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601079(3-chloro-4-[(2S)-2-(dimethylamino)-3-[(3R)-3-pheny...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601080(3-chloro-4-((S)-2-(dimethylamino)-3-((R)-4-methyl-...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601109(US11634396, Compound 68 | 4-((S)-2-(dimethylamino)...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601118(US11634396, Compound 77 | 4-((S)-2-(dimethylamino)...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601121(US11634396, Compound 80 | 4-((S)-3-((R)-3-(3,4-dic...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601124(US11634396, Compound 83 | 4-((S)-3-((R)-3-(4-chlor...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601127(US11634396, Compound 88 | 4-[(2S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601128(US11634396, Compound 89 | 4-[(2S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601129(US11634396, Compound 90 | 4-[(2S)-3-[(3S)-4-cyclob...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601130(US11634396, Compound 91 | 4-[(2S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601131(US11634396, Compound 92 | 4-((S)-2-(dimethylamino)...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601132(US11634396, Compound 95 | 4-[(2S)-3-[(3R)-4,4-dime...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601133(US11634396, Compound 94 | 4-[(2S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601132(US11634396, Compound 95 | 4-[(2S)-3-[(3R)-4,4-dime...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601135(US11634396, Compound 96 | 4-((S)-2-(dimethylamino)...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601136(US11634396, Compound 97 | 4-((S)-3-((R)-3-cyclopro...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601138(US11634396, Compound 101 | 4-((S)-3-((S)-4,4-dimet...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601142(US11634396, Compound 104 | 4-((S)-3-((S)-4,4-dimet...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601176(US11634396, Compound 136 | 4-((S)-3-((R)-3-(3,5-di...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601186(US11634396, Compound 142 | 4-((S)-3-((R)-3-(4-chlo...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601187(US11634396, Compound 143 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601189(US11634396, Compound 145 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601190(US11634396, Compound 146 | 4-((S)-3-((R)-4,4-dimet...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601191(US11634396, Compound 147 | 2-chloro-4-((S)-2-(dime...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601192(US11634396, Compound 148 | 2-chloro-4-((S)-2-(dime...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601193(US11634396, Compound 149 | 2-chloro-4-((S)-2-(dime...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601194(US11634396, Compound 150 | 2-chloro-4-((S)-3-((S)-...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601215(US11634396, Compound 155 | 4-((S)-3-((R)-3-(4-chlo...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601217(US11634396, Compound 156 | 4-((S)-3-((S)-3-(4-chlo...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601218(US11634396, Compound 157 | 4-((S)-3-((S)-4,4-dimet...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601219(US11634396, Compound 158 | 4-((S)-3-((S)-4,4-dimet...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601221(US11634396, Compound 159 | 4-((S)-3-((R)-4,4-dimet...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601223(US11634396, Compound 160 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601224(US11634396, Compound 161 | 44-((S)-2-(1H-imidazol-...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601225(US11634396, Compound 162 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601226(US11634396, Compound 163 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: <300nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601227(US11634396, Compound 164 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50:  1.65E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601228(US11634396, Compound 165 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

TargetDelta-type opioid receptor(Human)
Epiodyne

US Patent
LigandPNGBDBM601230(US11634396, Compound 167 | 4-((S)-2-(dimethylamino...)
Affinity DataEC50: >3.00E+3nMAssay Description:The dOR cAMP agonist and antagonist assays were conducted in a manner similar as described above for the mOR assays using CHO Tag-lite human dOR stab...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 472 total ) | Next | Last >>
Jump to: